Mobile Acceptance Questionnaire in Physiotherapy

February 15, 2024 updated by: METEHAN YANA, Karabuk University

Validity and Reliability of Turkish Version of Physiotherapy Mobile Acceptance Questionnaire

Many studies were conducted on the determinants and acceptance of mobile or wearable health care technology (mHealth). However, little research was done on physiotherapists' thinking regarding the use of mHealth. In this study, it was aimed to test the suitability of the Physiotherapy Mobile Acceptance Questionnaire -PTMAQ which was developed by Blumenthal et al. [6] to evaluate the physiotherapists' Perspectives on the Use of Mobile or Wearable Technology in their clinical practice, to the assessments of physiotherapists (to understand attitudes and possible barriers). PTMAQ, based on the Technology Acceptance Model (TAM) by Blumenthal et al. [6] was translated into Turkish and applied to Physiotherapists working in Turkey. Thus, it is expected that the results to be obtained after the scale is applied in Turkish language and in the Turkish sample will contribute to the further development of the scale. In this respect, the study is important both in terms of bringing a new PTMAQ to the literature and making suggestions to researchers and academicians who will use this scale in the future.

Study Overview

Status

Completed

Detailed Description

Due to the necessity of collecting data from a large sample to test the research's hypotheses, the questionnaire was chosen as the data collection instrument. The Physiotherapy Mobile Acceptance Questionnaire (PTMAQ) scale developed by Blumenthal et al. [6] was translated into Turkish and used for data collection on the variables of the study. In this scale, it was seen that a total of 8 expressions belonging to the Perceived usefulness (4 expressions) and Perceived ease of use (4 expressions) variables were used by making use of the TAM model to reveal the attitudes of the participants (physiotherapist) that could affect their intentions towards mHealth practice. Then, a question consisting of 4 statements was asked to reveal the effect of these variables on the intention to use of early adopters. Finally, 18 statements were used to measure the effect of intention to use on intention/likelihood to recommend an mHealth tool for specific clinical purposes.

Based on the clinical usefulness of MWT, these 18 statements want to determine the probability of physiotherapists recommending MWT to patients based on the clinical usefulness of using MWT in 3 dimensions (gait speed, gait quality and balance, pain/cognitive status). Responses were requested in a 5-point Likert format to the statements in the scale, according to which "1=Strongly Disagree" means "5=Strongly Agree". For the scale adaptation procedure, Blumenthal et al., the creators of the PTMAQ scale, were contacted via email and permission was secured. After that, five academics who had an excellent command on English translated it into Turkish. Attempts were made to establish language validity using the back translation technique. It was translated into the target language by an expert in the field of English, and the similarity was determined by translating it from the target language into English. Consequently, it was determined that the forms created independently in the two languages are comparable. Before conducting field research, a draft questionnaire was administered to forty physiotherapists, who were then interviewed face-to-face about concepts and expressions. In this manner, the potential miscommunication-causing wording errors in the questionnaire were reviewed, and the questionnaire was finalized.

Study Type

Observational

Enrollment (Actual)

421

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Karabük, Turkey, 78000
        • Karabuk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

A total of 421 physiotherapists will be included in the research.

Description

Inclusion Criteria:

  • Having completed at least 4 years of physiotherapy and rehabilitation education at undergraduate level and having the title of physiotherapist.
  • Being actively practicing their profession in universities, hospitals, rehabilitation centers, etc.
  • Being able to communicate in Turkish
  • Volunteering to participate in the study

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiotherapy Mobile Acceptance Questionnaire (PMAQ)
Time Frame: First Day

It is a survey consisting of 30 questions examining physiotherapists' adoption behaviors on mobile health. It consists of 12 items assessing adoption of technological applications and 18 items related to clinical variables for which mHealth technology can be recommended. Clinical variables in this context consist of (1) general activity level, (2) balance, (3) walking speed, (4) walking quality, (5) cognitive status and (6) pain. There are 5 answer options for each question, including: strongly disagree, disagree, undecided, agree, and strongly agree (6).

Additionally, following the survey, individuals' demographic information and smartphone ownership and usage status will be questioned.

First Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Metehan YANA PhD, Karabuk University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

February 15, 2024

Study Registration Dates

First Submitted

January 17, 2024

First Submitted That Met QC Criteria

January 17, 2024

First Posted (Actual)

January 26, 2024

Study Record Updates

Last Update Posted (Actual)

February 16, 2024

Last Update Submitted That Met QC Criteria

February 15, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reliability and Validity

Subscribe